ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,315Medicare Part D Prescriptions Filled, Including Refills

Rank: 151 out of 1278

$433K Total Retail Price of All Prescriptions

Rank: 173 out of 1278

481 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 481 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

21% of this provider’s 481 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 5,769 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
HYDROCODONE-ACETAMINOPHEN 462 279 S3 1 7
LEVOTHYROXINE SODIUM 345 293 2 2
LISINOPRIL 310 233 3 1
ZOLPIDEM TARTRATE 222 168 4 16
SIMVASTATIN 203 188 5 3
METFORMIN HCL 198 159 6 4
CARISOPRODOL 166 39 R 7 51
OXYCODONE-ACETAMINOPHEN 146 76 S2 8 29
AMLODIPINE BESYLATE 142 139 9 5
OMEPRAZOLE 136 110 10 6
LOVASTATIN 135 108 11 13
AZITHROMYCIN 134 94 12 37
HYDROCHLOROTHIAZIDE 120 103 13 8
GABAPENTIN 103 53 14 12
FUROSEMIDE 100 52 15 10
MORPHINE SULFATE ER 96 33 S2 16 42
METOPROLOL TARTRATE 94 71 17 9
ATENOLOL 90 70 18 11
NAPROXEN 89 53 19 70
OXYCODONE HCL 82 48 S2 20 27
FLUTICASONE PROPIONATE 80 56 21 24
ALLOPURINOL 78 72 22 36
OXYCODONE HCL-ACETAMINOPHEN 74 64 S2 23 76
CLOPIDOGREL 74 49 23 45
CIPROFLOXACIN HCL 72 59 25 53
TAMSULOSIN HCL 70 67 26 32
PANTOPRAZOLE SODIUM 69 58 27 34
LOSARTAN POTASSIUM 69 69 27 19
ESTRADIOL 67 36 R 29 71
DONEPEZIL HCL 66 66 30 48
PROAIR HFA 65 15 31 26
TRAMADOL HCL 64 21 32 25
CITALOPRAM HBR 64 58 32 22
CRESTOR 62 49 34 31
NAMENDA 60 60 35 77
SERTRALINE HCL 59 39 36 28
BENAZEPRIL HCL 57 51 37 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 43 37 30
POTASSIUM CHLORIDE 56 29 39 21
ROPINIROLE HCL 56 48 39 127
ADVAIR DISKUS 53 32 41 49
PLAVIX 50 41 42 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.